Mitsubishi Ufj Trust & Banking Corp I Mab Transaction History

Mitsubishi Ufj Trust & Banking Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$8.27 - $18.43 $193,418 - $431,040	-23,388 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$45.28 - $74.5 $7,924 - $13,037	175 Added 0.75%	23,388 $1.11 Million
Q3 2021 Nov 12, 2021	BUY	$57.18 - $84.43 $124,023 - $183,128	2,169 Added 10.31%	23,213 $1.68 Million
Q2 2021 Aug 12, 2021	BUY	$47.86 - $83.95 $1.01 Million - $1.77 Million	21,044 New	21,044 $1.77 Million

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $77.3M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.